Detalhe da pesquisa
1.
Inflammation at diagnosis and cognitive impairment two years later in breast cancer patients from the Canto-Cog study.
Breast Cancer Res
; 26(1): 93, 2024 Jun 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38840166
2.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 205(2): 267-279, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453781
3.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36161271
4.
Baseline quality of life and chemotherapy toxicities in patients with early breast cancer.
Cancer
; 129(7): 1085-1095, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642837
5.
Early Locoregional Breast Surgery and Survival in de novo Metastatic Breast Cancer in the Multicenter National ESME Cohort.
Ann Surg
; 277(1): e153-e161, 2023 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33534229
6.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988749
7.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882736
8.
Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study.
BMC Cancer
; 23(1): 736, 2023 Aug 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37559004
9.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36183733
10.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207609
11.
Self-referential processes and resting-state connectivity in breast cancer patients before and 1 year after chemotherapy.
Eur J Neurosci
; 55(2): 624-636, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34978117
12.
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer.
Breast Cancer Res Treat
; 191(1): 191-207, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34687411
13.
HELENA: HER2-Low as a prEdictive factor of response to Neoadjuvant chemotherapy in eArly breast cancer.
BMC Cancer
; 22(1): 1081, 2022 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36266623
14.
Uptake of Recommendations for Posttreatment Cancer-Related Fatigue Among Breast Cancer Survivors.
J Natl Compr Canc Netw
; 20(13)2022 02 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35130491
15.
Impact of creative art therapy on fatigue and quality of life in patients treated for localized breast cancer: A randomized study.
Psychooncology
; 31(8): 1412-1419, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35488808
16.
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
Breast Cancer Res
; 23(1): 9, 2021 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33468209
17.
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Br J Cancer
; 125(11): 1486-1493, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34588616
18.
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).
Breast Cancer Res Treat
; 190(2): 265-275, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476645
19.
Differentiation of groups of patients with cognitive complaints at breast cancer diagnosis: Results from a sub-study of the French CANTO cohort.
Psychooncology
; 30(4): 463-470, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33052613
20.
Risk of early progression according to circulating ESR1 mutation, CA-15.3 and cfDNA increases under first-line anti-aromatase treatment in metastatic breast cancer.
Breast Cancer Res
; 22(1): 56, 2020 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32466779